Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing aripiprazole for schizophrenia.
In CatonsvilleThis study was terminated in the United States. It focuses on Bipolarity.
In Bethesda
This study is completed in the United States. It focuses on schizophrenia.
In TowsonThis study is completed in France. It is testing efficacy, safety, pharmacokinetics and pharmacodynamics of a daily oral administration of MAP4343 during 6 weeks for Depression.
In FranceThis study was withdrawn. It focuses on ADHD.
Location not clearly listedThis study is completed in the United States. It focuses on depression.
In Cleveland
This study is completed in Finland. It focuses on Addiction.
In FinlandThis study is completed in Czechia. It focuses on depression.
In Czech RepublicThis study is ongoing in the United Kingdom. It focuses on depression.
In United KingdomThis study is completed in the United States, in France, in the United Kingdom, .... It is testing LDX for ADHD.
Multiple locations, including Rolling Hills EstatesThis summary needs review. Please check the official study record and contact the research team for details.
In ProvidenceThis summary needs review. Please check the official study record and contact the research team for details.
In HoustonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.